Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4501078 | 0.98 | NPSR1 (0.43) | NPSR1ALDH1A1KMT2ANPC1POLB | |
| SCHEMBL11085642 | 0.84 | CA2 (0.45) | ALDH1A1HTTCYP3A4 | |
| SCHEMBL5252736 | 0.84 | NPSR1 (0.43) | NPSR1ALDH1A1KMT2ANPC1POLB | |
| SCHEMBL9795580 | 0.83 | SMN1; SMN2 (0.59) | SMN1; SMN2 | |
| SCHEMBL8781767 | 0.83 | ALDH1A1 (0.44) | NPSR1ALDH1A1KMT2ANPC1POLB | |
| SCHEMBL9779961 | 0.81 | KEAP1 (0.40) | HTT | |
| SCHEMBL9795712 | 0.81 | KEAP1 (0.40) | KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL9780001 | 0.81 | KEAP1 (0.53) | ALDH1A1KMT2ARAB9ASMN1; SMN2L3MBTL1 | |
| Hydrochloric Acid SCHEMBL4512905 | 0.79 | KEAP1 (0.39) | CYP3A4 | |
| SCHEMBL11669414 | 0.79 | ALDH1A1 (0.41) | NPSR1ALDH1A1KMT2ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114743800-B | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2023-07-21 | — | — | CN | claimed |
| CN-114743800-A | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2022-07-12 | — | — | CN | claimed |
| US-8969288-B2 | Amide based glucagon and superfamily peptide prodrugs | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-03-03 | — | — | US | claimed |
| CN-102325539-A | Amide based glucagon superfamily peptide prodrugs | UNIV INDIANA RES & TECH CORP | 2012-01-18 | — | — | CN | claimed |
| US-20110288003-A1 | AMIDE BASED GLUCAGON AND SUPERFAMILY PEPTIDE PRODRUGS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2011-11-24 | — | — | US | claimed |
| EP-2376097-A1 | AMIDE BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS | Indiana University Research and Technology Corporation (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2010071807-A1 | AMIDE BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2010-06-24 | — | — | WO | claimed |
| EP-1483285-A1 | INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME | Curacyte AG (DE) | 2004-12-08 | — | — | EP | claimed |
| WO-2003076457-A1 | INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME | CURACYTE AG (DE) | 2003-09-18 | — | — | WO | claimed |
| US-4443371-A | LEATHER, PAPER | ALTHOUSE TERTRE, S.A. (BE) | 1984-04-17 | — | — | US | claimed |
| CN-114743800-B | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2023-07-21 | — | — | CN | disclosed |
| CN-114743800-B | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2023-07-21 | — | — | CN | disclosed |
| CN-113105351-B | Electric polarization particle, preparation method thereof and application thereof in electric polarization color-changing optical film | 绍兴迪飞新材料有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-114743800-A | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2022-07-12 | — | — | CN | disclosed |
| CN-114743800-A | Preparation method of polyacrylic acid/graphene-based flexible electrode material | 武夷学院 | 2022-07-12 | — | — | CN | disclosed |
| US-5324747-A | Treatment of inflammatory diseases | HOFFMANN-LA ROCHE INC. (US) | 1994-06-28 | — | — | US | disclosed |
| WO-1993020160-A1 | A METHOD AND LIQUID COMPOSITION FOR THE PRODUCTION OF INDELIBLE SCRIPT ON A PAPER SUBSTRATE | SEGALLA GABRIELE (IT) | 1993-10-14 | — | — | WO | disclosed |
| US-4985427-A | LIPOXYGENASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 1991-01-15 | — | — | US | disclosed |
| EP-0340030-A2 | Triazine derivatives | GLAXO GROUP LIMITED (GB) | 1989-11-02 | — | — | EP | disclosed |
| US-4459227-A | Para-hydroxyphenylhydrazines as in situ precursors of iminoquinones and quinones | DUKE UNIVERSITY (US) | 1984-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288003-A1 | AMIDE BASED GLUCAGON AND SUPERFAMILY PEPTIDE PRODRUGS | GCG, GLP1R, IAPP | NPSR1 957/4885ALDH1A1 2679/4885KMT2A 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.